Galicaftor Uses, Dosage, Side Effects and more
Galicaftor is under investigation in clinical trial NCT03540524 (A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis.).
| Attribute | Details |
|---|---|
| Trade Name | Galicaftor |
| Generic | Galicaftor |
| Galicaftor Other Names | Galicaftor |
| Type | |
| Formula | C28H21F4NO7 |
| Weight | Average: 559.47 Monoisotopic: 559.125414672 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
